Fischler M P, Kuhn M, Cantieni R, Frutiger A
Interdisciplinary Intensive Care Unit, Rätisches Kantons- und Regionalspital, Chur, Switzerland.
Intensive Care Med. 1995 Jun;21(6):475-81. doi: 10.1007/BF01706200.
Percutaneous dilatational tracheostomy is increasingly practiced in intensive care units and has a low incidence of early complications. The late effects of this procedure are still poorly known and were the focus of this study.
Prospective descriptive clinical study.
Interdisciplinary intensive care unit in a 300-bed teaching hospital.
A consecutive group of critically ill patients who underwent percutaneous tracheostomy between Nov. 90 and March 93, surviving at least 2 months after decannulation.
There were 17 patients fulfilling the inclusion criteria and 16 of them were seen and examined. The follow-up protocol required a formal standardized patient interview, a physical examination of the stoma site and a fiberoptic laryngotracheoscopy. Results of these sub-tests and overall outcome rating were standardized and expressed as good, moderate or poor. Subjective rating was good in all patients. All denied suffering from any side effects of their tracheostomy. Clinical examination revealed neither stridor nor hoarseness in any of the patients. Most of the scars were whitish and less than 1 cm in length, a few were sunken in, none had adhesions. In 15 patients the clinical result was good and in one, moderate (whitish, sunken-in scar, longer than 2 cm). Ten patients underwent tracheoscopy, while 6 did not. There were no signs of significant stenosis or tracheomalacia. In 8 patients with minor findings results were scored as good, while 2 were classified as moderate (combination of swelling and scar formation of a string-like membrane). The overall rating was good in 13 patients (81%) and moderate in 3 patients (19%). There were no poor outcomes.
Late outcome of percutaneous dilatational tracheostomy in critically ill patients is mostly good. Pending further studies, the use of this technique in intensive care units appears justified.
经皮扩张气管切开术在重症监护病房的应用日益广泛,且早期并发症发生率较低。该手术的远期影响仍鲜为人知,本研究以此为重点。
前瞻性描述性临床研究。
一所拥有300张床位的教学医院的跨学科重症监护病房。
1990年11月至1993年3月期间接受经皮气管切开术、拔管后存活至少2个月的一组连续的重症患者。
17例患者符合纳入标准,其中16例接受了检查。随访方案要求进行正式的标准化患者访谈、造口部位体格检查和纤维喉镜检查。这些子测试的结果和总体结果评分进行了标准化,并分为良好、中等或差。所有患者的主观评分均为良好。所有患者均否认气管切开术有任何副作用。临床检查显示所有患者均无喘鸣或声音嘶哑。大多数瘢痕呈白色,长度小于1cm,少数凹陷,无粘连。15例患者临床结果良好,1例中等(白色、凹陷瘢痕,长于2cm)。10例患者接受了气管镜检查,6例未接受。无明显狭窄或气管软化迹象。8例有轻微异常的患者结果评为良好,2例为中等(条索状膜肿胀和瘢痕形成)。13例患者(81%)总体评分为良好,3例(19%)为中等。无不良结果。
重症患者经皮扩张气管切开术的远期结果大多良好。在进一步研究之前,在重症监护病房使用该技术似乎是合理的。